Laura Rodriguez Gallego
Direktor/Vorstandsmitglied bei Onechain Immunotherapeutics
Profil
Laura Rodriguez Gallego is currently a Partner at Invivo Capital Partners SGEIC SA, a Board Member at OneChain Immunotherapeutics SL, and a Board Member at Telomere Therapeutics SL.
She completed her undergraduate degree at Universitat Autònoma de Barcelona in 2009, and her graduate and doctorate degrees at the University of Barcelona in 2011 and 2015 respectively.
Aktive Positionen von Laura Rodriguez Gallego
| Unternehmen | Position | Beginn |
|---|---|---|
Invivo Capital Partners SGEIC SA
 Invivo Capital Partners SGEIC SA Investment ManagersFinance Invivo Capital Partners SGEIC SA (Invivo Capital Partners) is a venture capital firm founded in 2019 by Albert Ferrer and Luis Pareras. The firm is headquartered in Barcelona, Spain. | Private Equity Investor | 01.01.2018 |
Telomere Therapeutics SL
 Telomere Therapeutics SL Pharmaceuticals: MajorHealth Technology Telomere Technologies provides telomere technology services. The company is headquartered in Spain. | Direktor/Vorstandsmitglied | 01.04.2024 |
Onechain Immunotherapeutics
 Onechain Immunotherapeutics Medical SpecialtiesHealth Technology Onechain Immunotherapeutics develops oncological therapeutic tools. The company is based in Barcelona, Spain. The Spanish company was founded in 2020 by Pablo Menéndez. The CEO is Jorge Alemany. | Direktor/Vorstandsmitglied | 01.01.2022 |
Ausbildung von Laura Rodriguez Gallego
| University of Barcelona | Doctorate Degree |
| Universitat Autònoma de Barcelona | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Invivo Capital Partners SGEIC SA
Invivo Capital Partners SGEIC SA Investment ManagersFinance Invivo Capital Partners SGEIC SA (Invivo Capital Partners) is a venture capital firm founded in 2019 by Albert Ferrer and Luis Pareras. The firm is headquartered in Barcelona, Spain. | Finance |
Telomere Therapeutics SL
Telomere Therapeutics SL Pharmaceuticals: MajorHealth Technology Telomere Technologies provides telomere technology services. The company is headquartered in Spain. | Health Technology |
Onechain Immunotherapeutics
Onechain Immunotherapeutics Medical SpecialtiesHealth Technology Onechain Immunotherapeutics develops oncological therapeutic tools. The company is based in Barcelona, Spain. The Spanish company was founded in 2020 by Pablo Menéndez. The CEO is Jorge Alemany. | Health Technology |
